External beam radiotherapy for clinically localized hormone-refractory prostate cancer: clinical significance of Nadir prostate-specific antigen value within 12 months.

@article{Ogawa2009ExternalBR,
  title={External beam radiotherapy for clinically localized hormone-refractory prostate cancer: clinical significance of Nadir prostate-specific antigen value within 12 months.},
  author={Kazuhiko Ogawa and Katsumasa Nakamura and Tomonari Sasaki and Hiroshi Onishi and Masahiko Koizumi and Yoshiyuki Shioyama and Masayuki Araya and Nobutaka Mukumoto and Michihide Mitsumori and Teruki Teshima},
  journal={International journal of radiation oncology, biology, physics},
  year={2009},
  volume={74 3},
  pages={759-65}
}
PURPOSE To analyze retrospectively the results of external beam radiotherapy for clinically localized hormone-refractory prostate cancer and investigate the clinical significance of nadir prostate-specific antigen (PSA) value within 12 months (nPSA12) as an early estimate of clinical outcomes after radiotherapy. METHODS AND MATERIALS Eighty-four patients with localized hormone-refractory prostate cancer treated with external beam radiotherapy were retrospectively reviewed. The total radiation… CONTINUE READING